期刊文献+

干细胞治疗疾病及安全性的研究进展 被引量:3

Advance in application and safety of stem cell therapy
原文传递
导出
摘要 近年来,干细胞治疗疾病是一个新的研究热点,在治疗心血管疾病、糖尿病、骨髓及软骨损伤、神经系统疾病以及恶性肿瘤等方面有广泛的应用。它是通过干细胞移植并迁移到损伤部位修复受损的细胞或组织的一种疗法,主要应用在因细胞或组织损伤引起的疾病,而且自体移植干细胞避免了免疫排斥和伦理道德问题。利用干细胞治疗这些疾病有一定的发展前景,为很多难以治愈的疾病提供了新的治疗途径和技术方法。然而,随着干细胞治疗疾病这项新技术的发展,安全性问题也引起了广泛的关注。因此,在干细胞应用到临床前,进行严格的安全性评价是很有必要的,这样才能保证干细胞治疗安全、稳定的造福于人类。 In recent years,stem cell therapy has become a new research hotspot and has been widely used in the treatment of cardiovascular disease,diabetes,bone and cartilage damage,neurological diseases,cancer,and so on. The stem cell therapy can repair damaged cell or tissue caused by related diseases through cell transplantation and cell migration. Moreover,the application of autologous stem cell transplantation effectively avoids the challenge of immune rejection and moral problems. In general,stem cell therapy has a good development prospect,and provides a new therapeutic approach and technique for many intractable diseases. However with the development of stem cell therapy,safety issues have attracted more and more attention. In order to ensure the safety of stem cells and the health of human,it is necessary to conduct a rigorous safety assessment before clinical application of stem cells.
出处 《中国新药杂志》 CAS CSCD 北大核心 2015年第5期509-512,544,共5页 Chinese Journal of New Drugs
基金 国家“重大新药创制”科技重大专项(2011ZX09301-003)
关键词 干细胞 干细胞移植 疾病 安全性 stem cells stem cell transplantation disease safety
  • 相关文献

参考文献5

二级参考文献69

  • 1Xi-Ming Xu,Guang-Jin Yuan,Jun-Jian Deng,Hong-Ting Guo,Miao Xiang,Fang Yang,Wei Ge and Shi-You Chen Cancer Center, Renmin Hospital of Wuhan University, Wuhan 430060, China ,Cancer Center, the 82nd Hospital of the Chinese PLA, Huai’an 223001, China ,Department of Physiology, Medical College of Wuhan University, Wuhan 430071, China ,Department of Physiology & Pharmacology, University of Georgia, Athens, GA 30602, USA.Inhibition of 12-lipoxygenase reduces proliferation and induces apoptosis of hepatocellular carcinoma cells in vitro and in vivo[J].Hepatobiliary & Pancreatic Diseases International,2012,11(2):193-202. 被引量:20
  • 2盛伟华,龚爱华,李明忠,谢宇锋,缪竞成,杨吉成,姜海燕,卢神州.几种丝素材料细胞毒性的实验研究[J].中国生物医学工程学报,2005,24(3):277-281. 被引量:14
  • 3徐正云,任国珍,马爱群.骨髓间质干细胞多向分化及其机制的研究进展[J].医学综述,2006,12(4):203-204. 被引量:4
  • 4裴雪涛,刘大庆.干细胞:组织器官重建的理想种子细胞[J].中国修复重建外科杂志,2006,20(4):344-348. 被引量:11
  • 5段巧艳,段祥,张焕相.丝素蛋白在组织工程中的应用[J].中国组织工程研究与临床康复,2007,11(26):5199-5203. 被引量:13
  • 6Canadian Cardiovascular Society, American Academy of Family Physicians,American College of Cardiology, et al. 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol.2008; 51(2): 210-247.
  • 7Yang EH, Barsness GW, Gersh B J, et al. Chandrasekaran K, Lerman A. Current and future treatment strategies for refractory angina. Mayo Clin Proc. 2004;79(10):1284-1292.
  • 8Boden WE. Management of chronic coronary disease: is the pendulum returning to equipoise? Am J Cardiol.2008; 101 (10A):69D-74D.
  • 9Mukherjee D, Bhatt DL, Roe MT, et al. Direct myocardial revascularization and angBeereiogenesis: how many patients might be eligible? Am J Cardiol. 1999;84(5):598-600.
  • 10Beeres SL, Atsma DE, van Ramshorst J, et al. Cell therapy for ischaemic heart disease. Heart.2008;94(9):1214-1226.

共引文献25

同被引文献19

引证文献3

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部